Meeting of the Microbiome Subcommittee of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

Issuing agencies

Abstract

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that an in-person meeting is scheduled to be held for the Microbiome Subcommittee of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 164 (Wednesday, August 26, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 164 (Wednesday, August 26, 2026)]
[Notices]
[Pages 55103-55104]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-17404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Microbiome Subcommittee of the Presidential 
Advisory Council on Combating Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice; 1st public meeting of the Microbiome Subcommittee of 
the Presidential Advisory Council on Combating Antibiotic-Resistant 
Bacteria.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that an in-person meeting is scheduled to be held for the Microbiome 
Subcommittee of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria (PACCARB).

DATES: The meeting is scheduled to be held on September 2, 2026, from 
12:00 p.m. to 5:00 p.m. ET (times are tentative and subject to change). 
The confirmed times and agenda items for the meeting will be posted on 
the website for the PACCARB at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> when this 
information becomes available.

ADDRESSES: The meeting will be held in-person at the Hubert H. Humphrey 
Building, Room 800, 200 Independence Avenue SW, Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Sarah Mcclelland, M.P.H., Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Email: <a href="/cdn-cgi/l/email-protection#1251534050527a7a613c757d64"><span class="__cf_email__" data-cfemail="9bd8dac9d9dbf3f3e8b5fcf4ed">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria (PACCARB), established by 
Executive Order 13676, is continued by Section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation 
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are 
governed by the provisions of the Federal Advisory Committee Act 
(FACA), Public Law 92-463, as amended (5 U.S.C. App.), which sets forth 
standards for the formation and use of federal advisory committees.
    The PACCARB shall advise and provide information and 
recommendations to the Secretary of Health and Human Services 
(Secretary) regarding programs and policies

[[Page 55104]]

intended to reduce or combat antibiotic-resistant bacteria that may 
present a public health threat and improve capabilities to prevent, 
diagnose, mitigate, or treat such resistance. The PACCARB shall 
function solely for advisory purposes.
    Such advice, information, and recommendations may be related to 
improving: the effectiveness of antibiotics; research and advanced 
research on, and the development of, improved and innovative methods 
for combating or reducing antibiotic resistance, including new 
treatments, rapid point-of-care diagnostics, alternatives to 
antibiotics, including alternatives to animal antibiotics, and 
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health 
care providers and the public with respect to up-to-date information on 
antibiotic resistance and ways to reduce or combat such resistance to 
antibiotics related to humans and animals; methods to prevent or reduce 
the transmission of antibiotic-resistant bacterial infections; 
including stewardship programs; and coordination with respect to 
international efforts in order to inform and advance the United States 
capabilities to combat antibiotic resistance.
    The focus of the September 2, 2026, meeting will be on current 
trends and gaps in microbiome science. The meeting will focus on 
innovative and emerging topics in antimicrobial resistance (AMR) and 
the microbiome. Written public comments can be emailed to <a href="/cdn-cgi/l/email-protection#7033312232301818035e171f06"><span class="__cf_email__" data-cfemail="e2a1a3b0a0a28a8a91cc858d94">[email&#160;protected]</span></a> 
by midnight August 31, 2026, and should be limited to no more than one 
page. All public comments received prior to September 2, 2026, will be 
provided to the subcommittee members.

Sarah Mcclelland,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for 
Health.
[FR Doc. 2026-17404 Filed 8-25-26; 8:45 am]
BILLING CODE 4150-44-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>